Interactive Financial Charts Not Available

Dr Agarwal's Health (AGARWALEYE) | Financial Analysis & Statements

Dr Agarwal's Health Care Ltd | Mid-cap | Healthcare

₹506.00

3.18%

Dr Agarwal's Health vs Poly Medicure Dr Agarwal's Health vs Laxmi Dental Dr Agarwal's Health vs Tarsons Products Dr Agarwal's Health vs Prevest Denpro Dr Agarwal's Health vs Shree Pacetronix Dr Agarwal's Health vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 4.9B

Gross Profit 2.1B 43.48%

Operating Income 649.1M 13.32%

Net Income 380.6M 7.81%

EPS (Diluted) ₹0.95

Balance Sheet Metrics

Total Assets 36.7B

Total Liabilities 17.4B

Shareholders Equity 19.3B

Debt to Equity 0.91

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Dr Agarwal's Health Income Statement From 2022 to 2025

Metric	2025	2024	2023	2022
Revenue i	17.0B	8.4B	10.2B	7.0B
Cost of Goods Sold i	9.4B	4.7B	5.6B	3.9B
Gross Profit i	7.7B	3.6B	4.6B	3.1B
Gross Margin % i	45.1%	43.3%	45.1%	44.5%
Operating Expenses
Research & Development i	-	-	-	-
Selling, General & Administrative i	1.1B	849.0M	609.4M	390.4M
Other Operating Expenses i	1.4B	1.4B	895.7M	643.4M
Total Operating Expenses i	2.5B	2.3B	1.5B	1.0B
Operating Income i	2.5B	917.5M	1.5B	960.2M
Operating Margin % i	14.6%	11.0%	15.1%	13.8%
Non-Operating Items
Interest Income i	92.3M	80.2M	48.5M	32.3M
Interest Expense i	1.1B	850.8M	719.7M	454.0M
Other Non-Operating Income	-	-	-	-
Pre-tax Income i	1.6B	446.6M	835.9M	567.6M
Income Tax i	495.1M	208.3M	-196.4M	136.0M
Effective Tax Rate % i	31.0%	46.6%	-23.5%	24.0%
Net Income i	1.1B	238.3M	1.0B	431.6M
Net Margin % i	6.5%	2.9%	10.2%	6.2%
Key Metrics
EBITDA i	4.9B	3.1B	2.8B	2.0B
EPS (Basic) i	₹2.80	₹0.75	₹2.98	-
EPS (Diluted) i	₹2.78	₹0.75	₹2.98	-
Basic Shares Outstanding i	297645892	315879846	315879846	-
Diluted Shares Outstanding i	297645892	315879846	315879846	-

Income Statement Trend

Dr Agarwal's Health Balance Sheet From 2022 to 2025

Metric	2025	2024	2023	2022
Assets
Current Assets
Cash & Equivalents i	1.0B	1.1B	1.3B	996.2M
Short-term Investments i	4.1B	4.7B	336.6M	-
Accounts Receivable i	1.2B	968.3M	763.3M	567.2M
Inventory i	802.7M	519.0M	360.4M	329.2M
Other Current Assets	185.3M	121.1M	-	-
Total Current Assets i	7.9B	7.6B	3.1B	2.3B
Non-Current Assets
Property, Plant & Equipment i	6.6B	4.9B	3.8B	2.8B
Goodwill i	19.3B	11.9B	7.6B	3.3B
Intangible Assets i	4.6B	2.7B	2.2B	387.6M
Long-term Investments	440.0M	0	0	0
Other Non-Current Assets	248.6M	104.7M	170.0K	-
Total Non-Current Assets i	28.8B	19.9B	15.1B	8.0B
Total Assets i	36.7B	27.5B	18.3B	10.3B
Liabilities
Current Liabilities
Accounts Payable i	1.5B	1.3B	1.0B	890.9M
Short-term Debt i	1.5B	1.3B	956.5M	630.6M
Current Portion of Long-term Debt	-	-	-	-
Other Current Liabilities	163.3M	109.7M	66.3M	70.1M
Total Current Liabilities i	4.8B	4.0B	3.0B	2.1B
Non-Current Liabilities
Long-term Debt i	8.1B	8.4B	7.6B	5.6B
Deferred Tax Liabilities i	69.6M	15.1M	24.5M	12.8M
Other Non-Current Liabilities	-	-	-	-
Total Non-Current Liabilities i	12.7B	9.7B	8.6B	5.9B
Total Liabilities i	17.4B	13.7B	11.7B	7.9B
Equity
Common Stock i	315.9M	93.3M	79.3M	68.6M
Retained Earnings i	-1.8B	-275.0M	-1.0B	-1.9B
Treasury Stock i	-	-	-	-
Other Equity	-	-	-	-
Total Shareholders Equity i	19.3B	13.8B	6.6B	2.3B
Key Metrics
Total Debt i	9.6B	9.7B	8.6B	6.2B
Working Capital i	3.2B	3.6B	88.6M	214.8M

Balance Sheet Composition

Dr Agarwal's Health Cash Flow Statement From 2022 to 2025

Metric	2025	2024	2023	2022
Operating Activities
Net Income i	1.6B	1.4B	835.9M	567.6M
Depreciation & Amortization i	-	-	-	-
Stock-Based Compensation i	83.8M	50.6M	18.3M	0
Working Capital Changes i	-1.3B	-356.0M	-301.8M	-332.8M
Operating Cash Flow i	1.4B	2.0B	1.2B	632.1M
Investing Activities
Capital Expenditures i	5.3M	42.5M	5.0M	8.1M
Acquisitions i	-5.2B	-2.9B	-3.2B	-797.1M
Investment Purchases i	-	-	-	-
Investment Sales i	-	-	-	-
Investing Cash Flow i	-5.2B	-2.8B	-3.2B	-789.0M
Financing Activities
Share Repurchases i	-	-	-	-
Dividends Paid i	-7.9M	-7.7M	-4.3M	-70.0K
Debt Issuance i	615.2M	2.5B	1.7B	1.1B
Debt Repayment i	-2.0B	-2.2B	-779.6M	-184.5M
Financing Cash Flow i	5.2B	6.7B	4.0B	1.1B
Free Cash Flow i	394.3M	1.1B	753.0M	937.4M
Net Change in Cash i	1.5B	5.8B	2.0B	916.9M

Cash Flow Trend

Dr Agarwal's Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 156.13

Forward P/E 89.83

Price to Book 8.45

Price to Sales 8.80

Profitability Ratios

Profit Margin 5.66%

Operating Margin 13.32%

Return on Equity 4.33%

Return on Assets 2.27%

Financial Health

Current Ratio 1.66

Debt to Equity 49.87

Per Share Data

EPS (TTM) ₹3.20

Book Value per Share ₹59.09

Revenue per Share ₹58.45

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
agarwaleye	158.0B	156.13	8.45	4.33%	5.66%	49.87
Poly Medicure	192.4B	53.76	7.11	12.24%	21.18%	6.52
Laxmi Dental	18.4B	77.43	8.57	15.22%	9.53%	9.35
Tarsons Products	16.0B	57.62	2.53	4.72%	6.90%	53.82
Prevest Denpro	6.6B	34.61	6.19	17.20%	28.86%	0.00
Shree Pacetronix	836.4M	77.65	5.88	5.44%	6.03%	36.79

Financial data is updated regularly. All figures are in the company's reporting currency.